Erdogan Esra, Yetisgen Azize, Keskin Lezzan, Tanriverdi Elif Seren, Benk Ugur Isilay Gokce
Department of Basic Pharmacy Sciences, Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye.
Department of Infectious Diseases, Malatya Training and Research Hospital, Malatya, Türkiye.
Mol Biol Rep. 2025 Mar 18;52(1):323. doi: 10.1007/s11033-025-10427-0.
With the increase in the incidence of diabetes mellitus (DM) in recent years, diabetic foot ulcers (DFU), which are common and serious chronic complications of diabetes, have also become widespread. DFU is highly associated with a significant deterioration in quality of life as well as increased morbidity and mortality. Meteorin is a potent neurotrophic growth factor and shows antiangiogenic, antihyperalgesic, antinociceptive and neuroprotective effects. This study aimed to determine the possible relationship between meteorin, diabetes and diabetic foot ulcer by comparing the serum meteorin levels of healthy control group, DM patients and patients with diabetic foot ulcers.
Our study included a total of 62 diabetic patients, 31 of whom had DFU, and 29 healthy individuals as a control group. Meteorin levels of the participants were measured using ELISA method in serum samples. Other laboratory and epidemiological data of the patients were obtained from the hospital database.
In the wound cultures taken from patients with DFU, the most commonly isolated bacteria were Staphylococcus aureus and Pseudomonas aeruginosa. Serum meteorin levels were found to be statistically significantly higher in diabetic patients as compared to the healthy control group, and among diabetic patients, those with DFU had significantly higher levels compared to those without DFU. A positive significant correlation was found between meteorin level and age, HbA1c, WBC, urea, sedimentation, CRP and ferritin.
The results of our study, aimed at better understanding the biological functions and potential clinical applications of meteorin, suggest that meteorin could potentially be used as a biomarker for the development of DFU.
近年来,随着糖尿病(DM)发病率的上升,糖尿病足溃疡(DFU)这一常见且严重的糖尿病慢性并发症也日益普遍。DFU与生活质量显著下降以及发病率和死亡率增加密切相关。陨石蛋白是一种有效的神经营养生长因子,具有抗血管生成、抗痛觉过敏、抗伤害感受和神经保护作用。本研究旨在通过比较健康对照组、DM患者和糖尿病足溃疡患者的血清陨石蛋白水平,确定陨石蛋白、糖尿病和糖尿病足溃疡之间可能的关系。
我们的研究共纳入62例糖尿病患者,其中31例患有DFU,以及29名健康个体作为对照组。采用酶联免疫吸附测定(ELISA)法检测参与者血清样本中的陨石蛋白水平。患者的其他实验室和流行病学数据来自医院数据库。
在从DFU患者采集的伤口培养物中,最常分离出的细菌是金黄色葡萄球菌和铜绿假单胞菌。与健康对照组相比,糖尿病患者的血清陨石蛋白水平在统计学上显著更高,并且在糖尿病患者中,患有DFU的患者水平显著高于未患有DFU的患者。发现陨石蛋白水平与年龄、糖化血红蛋白(HbA1c)、白细胞(WBC)、尿素、血沉、C反应蛋白(CRP)和铁蛋白之间存在显著正相关。
我们旨在更好地了解陨石蛋白生物学功能和潜在临床应用的研究结果表明,陨石蛋白可能潜在地用作DFU发生发展的生物标志物。